| P50 | author | Huzwah Khaza'ai | Q56705002 |
| | Barakatun Nisak Mohd Yusof | Q57359124 |
| P2093 | author name string | Azrina Azlan | |
| | Maryam Mashmoul | |
| | Sabariah Mohd Noor | |
| P2860 | cites work | Medical Consequences of Obesity | Q22241663 |
| | Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice | Q24805490 |
| | Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.) | Q28215369 |
| | Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice | Q46163787 |
| | Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition | Q46183901 |
| | Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats | Q46410396 |
| | Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet | Q46500697 |
| | Calcium antagonistic effects of Chinese crude drugs: preliminary investigation and evaluation by 45 Ca. | Q46512537 |
| | Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. | Q46677224 |
| | Crocetin prevents dexamethasone-induced insulin resistance in rats | Q46778659 |
| | Inflammatory biomarkers: the link between obesity and associated pathologies | Q46923820 |
| | Effects of three Chinese herbal medicines on plasma and liver lipids in mice fed a high-fat diet | Q47187079 |
| | Long-term persistence of hormonal adaptations to weight loss | Q47347342 |
| | Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats | Q49029777 |
| | Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. | Q51930780 |
| | Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. | Q55039667 |
| | Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials | Q73944956 |
| | The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study | Q77378715 |
| | Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails | Q79364793 |
| | Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats | Q79534215 |
| | Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties | Q79689779 |
| | Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase | Q79861789 |
| | Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats | Q83815842 |
| | Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats | Q84937038 |
| | Crocin, a dietary additive protects platelets from oxidative stress-induced apoptosis and inhibits platelet aggregation | Q87442820 |
| | Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents | Q28272906 |
| | Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents | Q28284395 |
| | Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells | Q28293743 |
| | Effect of crocin on experimental atherosclerosis in quails and its mechanisms | Q33217381 |
| | The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis | Q33422129 |
| | Obesity and medicinal plants | Q33994048 |
| | Saffron chemoprevention in biology and medicine: a review. | Q34062338 |
| | Antioxidant property of Saffron in man. | Q34067867 |
| | Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women | Q34122747 |
| | Inflammation: the link between insulin resistance, obesity and diabetes | Q34286695 |
| | Is obesity an inflammatory condition? | Q34463786 |
| | Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. | Q34573384 |
| | Pancreatic lipase inhibitors from natural sources: unexplored potential | Q34700628 |
| | Quality of life and obesity | Q34742754 |
| | Inflammation, oxidative stress, and obesity | Q35048584 |
| | Dietary total antioxidant capacity is inversely related to central adiposity as well as to metabolic and oxidative stress markers in healthy young adults. | Q35231169 |
| | Crocetin reduces the oxidative stress induced reactive oxygen species in the stroke-prone spontaneously hypertensive rats (SHRSPs) brain. | Q35522372 |
| | Crocetin from saffron: an active component of an ancient spice | Q35828694 |
| | Recent advances in the relationship between obesity, inflammation, and insulin resistance. | Q36448850 |
| | Saffron in phytotherapy: pharmacology and clinical uses | Q36912860 |
| | Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity | Q36966082 |
| | Phytochemicals and regulation of the adipocyte life cycle | Q37169957 |
| | Recent advances in obesity pharmacotherapy | Q37370203 |
| | A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases | Q37411550 |
| | Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. | Q37453072 |
| | New applications and mechanisms of action of saffron and its important ingredients. | Q37787105 |
| | Crocetin: an agent derived from saffron for prevention and therapy for cancer | Q37861776 |
| | Obesity and metabolic syndrome: potential benefit from specific nutritional components. | Q37901903 |
| | Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress | Q37953571 |
| | Carotenoids and polyphenols in nutricosmetics, nutraceuticals, and cosmeceuticals | Q37987558 |
| | Anti-inflammatory properties of drugs from saffron crocus. | Q38039178 |
| | Cardiovascular effects of saffron: an evidence-based review. | Q38052907 |
| | Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats | Q43219311 |
| | Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice | Q44486826 |
| | Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). | Q44643380 |
| | Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial | Q45262576 |
| | Treatment of obesity with "combination" pharmacotherapy | Q46057959 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 293-308 | |
| P577 | publication date | 2013-10-29 | |
| P1433 | published in | Antioxidants (Basel, Switzerland) | Q27726919 |
| P1476 | title | Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug | |
| P478 | volume | 2 | |